ArkAb is being created

The company ArkAb, B Cell Design’s subsidiary, will be created in the coming days. Focused on the in vitro diagnostic market, ArkAb develops, produces and sells monoclonal chimeric antibodies, particularly as a sustainable and reproducible alternative to disease state plasma, used as quality controls in in vitro diagnostic assays.

Go back

This website uses cookies, by continuing to browse this website you agree to our cookie policy.